In a similar way, in a knock-in mouse model in which the PAX5-ELN transgene is expressed specifically in B cells, 80% of the mice developed B-ALL [66]; in these animals, leukemic transformation needs recurrent secondary mutations on genes affecting key signalling pathways required for cell proliferation [66]. The gene discussed is PAX5; the disease is precursor B-cell acute lymphoblastic leukemia.